NASDAQ:LXEO | Cash Flow Statement | Lexeo Therapeutics, Inc.

Complete source-backed cash-flow history.

Available history
2022-03-31 to 2026-06-30
Data captured

Historical Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2026-06-30-$25.87M
2026-03-31-$20.2M-$21.14M$35,000.00$27.46M$2.45M
2025-12-31-$20.92M-$20.08M$0.00-$101.69M$143.77M
2025-09-30-$20.28M
2025-06-30-$26.1M
2025-03-31-$32.66M-$21.72M$15.6M$11,000.00
2024-12-31-$25.92M-$28.33M$0.00-$93.58M-$97,000.00
2024-09-30-$29.49M
2024-06-30-$21.24M
2024-03-31-$21.68M-$14.87M$185,000.00-$193,000.00$88.65M
2023-12-31-$14.19M-$13.98M$73,000.00-$73,000.00$100.07M
2023-09-30-$20.11M
2023-06-30-$13.44M
2023-03-31-$18.66M-$18.37M-$98,000.00
2022-12-31-$14.58M-$16.63M$25,000.00-$107,000.00-$81,000.00
2022-09-30-$17.06M
2022-06-30-$15.14M
2022-03-31-$12.5M

Annual Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2025-12-31-$99.96M-$98.56M$397,000.00-$90.25M$216.8M
2024-12-31-$98.33M-$81.15M$481,000.00-$94.08M$88.78M
2023-12-31-$66.39M-$59.5M$115,000.00-$165,000.00$103.79M
2022-12-31-$59.28M-$54.56M$672,000.00-$901,000.00$189,000.00